Back to Search
AREEJ YOUNES, MD
MD
Pediatric Endocrinology Physician
NPI: 1215190863Individual
Specialties, Licenses & Credentials
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
35128575(OH)55300(AZ)
Research & Publications (20)
Cholinergic receptor signaling modulates spontaneous firing of sinoatrial nodal cells via integrated effects on PKA-dependent Ca(2+) cycling and I(KACh).
PMID 19542482·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Heterogeneous pathways of maternal-fetal transmission of human viruses (review).
PMID 19350418·Pathol Oncol Res·2009
6-review
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma.
PMID 19465429·Ann Oncol·2009
8-other
p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis.
PMID 19342895·Cell Cycle·2009
7-preclinical
Variable-density flow in heterogeneous porous media--laboratory experiments and numerical simulations.
PMID 19674812·J Contam Hydrol·2009
8-other
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
PMID 19636010·J Clin Oncol·2009
3-trial
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.
PMID 18079362·Blood·2008
3-trial
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
PMID 18764869·Br J Haematol·2008
3-trial
Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma.
PMID 18542117·Nat Clin Pract Oncol·2008
8-other
Current role of gemcitabine in the treatment of Hodgkin lymphoma.
PMID 18452104·Leuk Lymphoma·2008
6-review
Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answers.
PMID 18469512·Autophagy·2008
6-review
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
PMID 18083690·Ann Oncol·2008
8-other
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
PMID 18085611·Cancer·2008
3-trial
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
PMID 18223284·Haematologica·2008
3-trial
Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
PMID 18509186·J Clin Oncol·2008
6-review
Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
PMID 18343280·Exp Hematol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1920 E CAMBRIDGE AVE STE 301
PHOENIX, AZ 85006 - Phone
- (602) 933-0935
Quick Facts
- NPI
- 1215190863
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile